HER2 directed therapy for gastric/esophageal cancers

Current treatment options in oncology

Volumn 15, Issue 3, 2014, Pages 395-404

  Won, Elizabeth ^a   Janjigian, Yelena J ^a   Ilson, David H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ANTAGONISTS AND INHIBITORS; DIET; DRUG RESISTANCE; ESOPHAGEAL NEOPLASMS; HUMAN; LIFESTYLE; METABOLISM; MOLECULARLY TARGETED THERAPY; PROGNOSIS; STOMACH NEOPLASMS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIET; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; HUMANS; LIFE STYLE; MOLECULAR TARGETED THERAPY; PROGNOSIS; RECEPTOR, ERBB-2; STOMACH NEOPLASMS;

EID: 85027926361     PISSN: None     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-014-0292-6     Document Type: Review

References (0)